CAR-T靶点蛋白—非标记蛋白

¥1200 - 28000
ACROBiosystems
USA
2021-07-15 21:46

我要认领
占女士
400-682-2521
order.cn@acrobiosystems.com
产品属性
英文名Indirect detection using unconjugated proteins
供应商ACROBiosystems
规格不同产品价格不同
产品说明

间接检测法 —— 非标记蛋白



产品特点
  • 靶抗原带有融合表位标签,随后可使用荧光标记的表位标签抗体作为二抗进行检测
  • 可高灵敏度地检测CAR阳性表达率
  • 有可能产生因二抗交叉反应引起的非特异性背景
> Fc-tag fusion proteins -> Specially designed(点击分子即可查看产品详情
BCMACD19CD30CD33
CD38CD70EGFRFOLR1
GPC3HER2HGFRIL13R
MSLNMUC1ROR1EpCAM

> His-tag fusion proteins -> Specially designed(点击分子即可查看产品详情
BCMACD19CD123CD138CD22CD30
CD33CD38CD70CAIXEGFREGFRVIII
EpCAMFOLR1GPC3HER2HGFRMSLN
ROR1

> All fusion proteins -> Specially designed(点击分子即可查看产品详情
BCMACD19CD123CD138CD22CD30
CD33CD38CD70CAIXEGFREGFRVIII
EpCAMFOLR1GPC3HER2HGFRIL13RA2
MSLNMUCIROR1

> 应用案例

使用Human CD19, Fc Tag蛋白检测Anti-CD19-CAR表达阳性率


293 cells were transfected with FMC63-scFv and RFP tag. 2e5 of the cells were first stained with B. Human CD19 (20-291) Protein, Fc Tag, low endotoxin (Super affinity) (Cat. No. CD9-H5251, 3 µg/ml) and C. Human Fc Tag Protein Control, followed by FITC-conjugated Anti-human IgG Fc Antibody. A. Non-transfected 293 cells and C. Human Fc Tag Protein Control were used as negative control. RFP was used to evaluate CAR (anti-CD19-scFv) expression and FITC was used to evaluate the binding activity of Human CD19 (20-291) Protein, Fc Tag, low endotoxin (Super affinity) (Cat. No. CD9-H5251).

> 如需了解更多此产品信息,可点击:ACROBiosystems官网,输入货号,即可查看产品详情,也可直接拨打:400-682-2521进行咨询

ACROBiosystems作为专注于医药研发领域的蛋白供应商,利用专业的蛋白研发平台、蛋白标记平台、稳定株开发平台和流式细胞分析平台,开发了一系列包括非标记、生物素标记、荧光标记等多种形式的CAR-T靶点蛋白以及配套的流式细胞法检测CAR阳性率的protocol,以助力CAR-T的研发,加速CAR-T研发的进程。目前产品已覆盖BCMA,CD19,ROR1,EGFRVIII等20余个CAR-T热门靶点。